Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
3,137.10
+2.10 (0.07%)
Jun 4, 2025, 3:29 PM IST
Torrent Pharmaceuticals Revenue
In the fiscal year ending March 31, 2025, Torrent Pharmaceuticals had annual revenue of 115.16B INR with 7.35% growth. Torrent Pharmaceuticals had revenue of 29.59B in the quarter ending March 31, 2025, with 7.80% growth.
Revenue
115.16B
Revenue Growth
+7.35%
P/S Ratio
9.21
Revenue / Employee
7.33M
Employees
15,718
Market Cap
1,061.06B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 115.16B | 7.88B | 7.35% |
Mar 31, 2024 | 107.28B | 11.08B | 11.51% |
Mar 31, 2023 | 96.20B | 11.12B | 13.07% |
Mar 31, 2022 | 85.08B | 5.03B | 6.29% |
Mar 31, 2021 | 80.05B | 652.60M | 0.82% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 525.78B |
Divi's Laboratories | 93.60B |
Cipla | 271.45B |
Mankind Pharma | 122.07B |
Apollo Hospitals Enterprise | 217.94B |
Zydus Lifesciences | 232.42B |
Aurobindo Pharma | 317.24B |
Alkem Laboratories | 129.65B |
Torrent Pharmaceuticals News
- 14 days ago - Pharma stocks rally: Glaxo surges 7%, Torrent gains after Q4; Gland steady post mixed results - Business Upturn
- 14 days ago - Torrent Pharma shares jump 3% as Q4 EBITDA rises 9.2% YoY to Rs 964 crore - Business Upturn
- 14 days ago - Torrent Pharma share price: Nomura sees 11% upside, maintains neutral after Q4 miss due to one-off - Business Upturn
- 14 days ago - Torrent Pharma share price: Nuvama expects 16% upside, cites India, US growth and semaglutide launches - Business Upturn
- 15 days ago - Aman Mehta to lead Torrent Pharma in generational transition - The Times of India
- 2 months ago - Torrent Pharmaceuticals issues Rs 300 crore worth of commercial papers at 7.13% discount rate - Business Upturn
- 4 months ago - Torrent Pharmaceuticals Ltd (BOM:500420) Q3 2025 Earnings Call Highlights: Strong India Growth ... - GuruFocus
- 4 months ago - Q3 2025 Torrent Pharmaceuticals Ltd Earnings Call Transcript - GuruFocus